Products

Products

Home page

API

Gadobutrol Monohydrate

Varenicline Tartrate

Gadoterate Meglumine

Fosaprepitant Dimeglumine

News Center

Viwit Pharmaceuticals' Sterile Production Facility Successfully Passes U.S. FDA Inspection

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

← Back to previous page

Gadobutrol Monohydrate

Product Name:

Gadobutrol Monohydrate

CAS#:

198637-52-4

Specification:Ph. Eur., Ch.P

Character/Appearance:White or off-white powder.

Assay:Gadobutrol: 97.5%-102.5% (w/w)
Gadolinium: 98.0%-102.0% (w/w)

Applications:A gadolinium-based MRI contrast agent for CNS examination.

Package:Pack as per customer requirement.

Storage:Airtight and protect from light

VIWIT

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search